Log In
Print
BCIQ
Print
Print this Print this
 

KHK7580

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionCalcium receptor agonist
Molecular Target
Mechanism of ActionCalcium-sensing receptor (CaSR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationThyroid disease
Indication DetailsTreat hyperparathyroidism in patients receiving hemodialysis; Treat secondary hyperparathyroidism (SHPT)
Regulatory Designation

Partner

Kyowa Hakko Kirin Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today